These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36006128)

  • 21. Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans.
    Calvert L; Green MP; De Iuliis GN; Dun MD; Turner BD; Clarke BO; Eamens AL; Roman SD; Nixon B
    Front Endocrinol (Lausanne); 2021; 12():799043. PubMed ID: 35356147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping DEHP to the adverse outcome pathway network for human female reproductive toxicity.
    Pogrmic-Majkic K; Samardzija Nenadov D; Tesic B; Fa Nedeljkovic S; Kokai D; Stanic B; Andric N
    Arch Toxicol; 2022 Oct; 96(10):2799-2813. PubMed ID: 35790550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content.
    Martens M; Evelo CT; Willighagen EL
    Appl In Vitro Toxicol; 2022 Mar; 8(1):2-13. PubMed ID: 35388368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
    Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
    Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To which extent are per-and poly-fluorinated substances associated to metabolic syndrome?
    Zare Jeddi M; Soltanmohammadi R; Barbieri G; Fabricio ASC; Pitter G; Dalla Zuanna T; Canova C
    Rev Environ Health; 2022 Jun; 37(2):211-228. PubMed ID: 34036763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Per- and Polyfluoroalkyl Substances (PFAS) in Integrated Crop-Livestock Systems: Environmental Exposure and Human Health Risks.
    Jha G; Kankarla V; McLennon E; Pal S; Sihi D; Dari B; Diaz D; Nocco M
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
    Ravichandran J; Karthikeyan BS; Samal A
    Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
    Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
    Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water: A review of the recent scientific literature.
    Domingo JL; Nadal M
    Environ Res; 2019 Oct; 177():108648. PubMed ID: 31421451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exposure to per- and polyfluoroalkyl substances on vaccine antibodies: A systematic review and meta-analysis based on epidemiological studies.
    Zhang X; Xue L; Deji Z; Wang X; Liu P; Lu J; Zhou R; Huang Z
    Environ Pollut; 2022 Aug; 306():119442. PubMed ID: 35568291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
    Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
    Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding Public Perceptions of Per- and Polyfluoroalkyl Substances: Infodemiology Study of Social Media.
    Tian H; Gaines C; Launi L; Pomales A; Vazquez G; Goharian A; Goodnight B; Haney E; Reh CM; Rogers RD
    J Med Internet Res; 2022 Mar; 24(3):e25614. PubMed ID: 35275066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Ye X; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Int; 2018 Jun; 115():358-369. PubMed ID: 29705692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-Life Exposure to Per- and Poly-Fluorinated Alkyl Substances and Growth, Adiposity, and Puberty in Children: A Systematic Review.
    Lee YJ; Jung HW; Kim HY; Choi YJ; Lee YA
    Front Endocrinol (Lausanne); 2021; 12():683297. PubMed ID: 34566884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.
    Qi W; Clark JM; Timme-Laragy AR; Park Y
    Toxicol Environ Chem; 2020; 102(1-4):1-36. PubMed ID: 33304027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of paternal and maternal per- and polyfluoroalkyl substances exposure with cord serum reproductive hormones, placental steroidogenic enzyme and birth weight.
    Yao Q; Gao Y; Zhang Y; Qin K; Liew Z; Tian Y
    Chemosphere; 2021 Dec; 285():131521. PubMed ID: 34273704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomonitoring of emerging contaminants, perfluoroalkyl and polyfluoroalkyl substances (PFAS), in New Jersey adults in 2016-2018.
    Yu CH; Riker CD; Lu SE; Fan ZT
    Int J Hyg Environ Health; 2020 Jan; 223(1):34-44. PubMed ID: 31679856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.